… Study aim and design The aim of this study is to compare addition of mifepristone to the
standard treatment with misoprostol in terms of complete evacuation of products of conception …

… Thus, this study does not support a phase 3 trial in this … is a steroid with antiglucocorticoid
and antiprogesterone properties … This study was a 12-week, double-blind, placebo-controlled, …

… three (200 or 400 μg at gestation > 16 weeks or ≤ 16 weeks, respectively, six-hourly) [18,
19]. In the present study, we administered a second dose of mifepristone … -dose mifepristone …

… Indeed, this agent has prevented malignant formation in Brca1-deficient mice [29]. …
available number of healthy volunteers treated with antiprogestins (Clinical Trials 1-3, ‘Mifepristone …

… In a double-blind presurgical window trial of oral telapristone … of antiprogestin therapies for
breast cancer treatment and … Higher doses of single-agent mifepristone have been tested in …

… doses of uterotonic agents after mifepristone treatment is the … by randomized, double-blind,
and controlled trials with larger … As an antiprogesterone, mifepristone causes upregulation of …

… (IND), to treat up to 40 patients with stage IIIB or IV non-small … “A phase II study of treatment
with oral mifepristone as salvage … response to single agent mifepristone, which activates the …

… Use of mifepristone as a hormonal agent for meningiomas … to achieve an antiprogesterone
effect without significant … One double-blind phase 3 multicentric randomized controlled trial …

… The use of pharmacological agents or mechanical methods to promote cervical ripening …
, this randomised trial is the first to compare the outpatient and inpatient use of mifepristone for …

… Like mifepristone, UPA was labelled an ‘antiprogestin’ when initially … of phase III clinical trials
utilising UPA for management of … vs placebo in a randomised, double-blind, parallel-group …